Clinical impact of the 21-gene recurrence score on adjuvant treatment selection in elderly patients with hormone receptor-positive, HER2-negative early breast cancer.

BMC Cancer · 2026 · PMC13191881 · PMID 41965577

Europe PMC DOI

hedged sentence

0.1060

closest p · 2.1× alpha

0.1060

boldest claim

The sentences

did not reach statistical significancep = 0.106not close (p > 0.1)

In the high-RS group, intravenous chemotherapy tended to be used more frequently in elderly patients, whereas standard endocrine therapy was more frequently selected in non-elderly patients; however, this between-group difference did not reach statistical significance ( p = 0.106).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.